Honor for leading WCM-Q faculty member
Dr. Chris Triggle, who joined WCM-Q in 2007, has been made a Fellow of the British Pharmacological Society.
One of WCM-Q’s senior research faculty members has been elected a fellow of a leading medical society in his home country.
Dr. Chris Triggle, who joined WCM-Q in 2007, was made a Fellow of the British Pharmacological Society (BPS) in recognition of his contributions to the discipline of pharmacology over the course of a distinguished career that to date has spanned more than four decades.
Dr. Triggle, Professor of Pharmacology, is a leading authority on the effects of metformin, the world’s most widely used type 2 diabetes medication. His latest research has helped demonstrate that in addition to keep blood sugar levels under control by improving insulin sensitivity, metformin appears to have beneficial side-effects including anti-aging and anti-cancer properties.
Dr. Triggle said: “I feel very honored and happy to have been recognized by the society, which was completely unexpected and a very pleasant surprise. The BPS is a proactive society that does a great deal of good work to represent the discipline of pharmacology and also, crucially, to help translate basic research into clinical advances.”
BPS materials say of being elected a Fellow of the Society (FBPhS): “Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology over a sustained period. Our Fellows have made substantial contributions to the discipline and the Society, through their work, publications, and attendance at, and contribution to, Society meetings.”
Dr. Triggle was previously President of the Pharmacological Society of Canada (now the Canadian Society of Pharmacology & Therapeutics) and of the Western Pharmacology Society, an international organization. He also served on the international scientific advisory committee for two International Union of Pharmacology (IUPHAR) meetings, and chaired and helped organize multiple symposia, at which all of the national societies meet every four years, as well as many other international scientific meetings. He was the head of the Department of Pharmacology & Therapeutics at the University of Calgary, Canada from 1990 to 1999 and has been published multiple times in many leading journals, including the British Journal of Pharmacology, of which he was Associate Editor at one time.
Dr. Triggle added: “In my career I have been fortunate to see many dramatic advances in pharmacology research and the subsequent development of new and more effective drugs for treating many illness – it has been a very exciting time for the discipline. Looking forward, the new era of personalized medicine is already beginning to deliver very promising advances, particularly in chemotherapy drugs for treating cancer, but also in many other areas, so it looks as though there are even more exciting times ahead.”
Dr. Khaled Machaca, Associate Dean for Research, said: “The election of Dr. Triggle to the BPS, one of the most prestigious pharmacological societies, is indeed a great and well deserved honor. Dr. Triggle’s research has been well-recognized internationally and has had considerable impact. During his tenure at Weill Cornell Medicine-Qatar he has built earnestly on the achievements of his earlier career, which has led to this important and significant honor.”